List of insiders holdings for REPLIGEN CORP:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| EDDLEMAN ROY T 10% Owner | 2024-02-06 13:41:19 | 2,705,689 0 | 2,705,689 | Form 13G |
| SCHIMMEL PAUL Director | 2007-06-18 17:01:47 | 670,106 0 | 670,106 | Form 4 |
| HERLIHY WALTER C PRESIDENT, CEO | 2015-05-14 12:45:14 | 262,430 0 | 262,430 | Form 4 |
| Lieber Jonathan I CFO | 2013-03-12 09:31:28 | 165,000 0 | 165,000 | Form 4 |
| Hunt Anthony Director | 2024-12-05 20:26:45 | 160,504 0 | 160,504 | Form 4 |
| MUEHL DANIEL W CFO | 2006-03-01 14:01:53 | 120,000 0 | 120,000 | Form 4 |
| WITT DANIEL P Senior Vice President | 2014-06-24 09:38:52 | 117,999 0 | 117,999 | Form 4 |
| Spurr Robert Chief Commercial. Officer | 2012-03-12 16:58:58 | 110,000 0 | 110,000 | Form 3 |
| RICH ALEXANDER Director | 2011-12-19 16:18:26 | 105,000 0 | 105,000 | Form 4 |
| Hall Michael Chief Medical Officer | 2012-03-12 16:53:39 | 105,000 0 | 105,000 | Form 3 |
| Harris Timothy Scott VP Corporate Development | 2006-03-01 14:01:40 | 100,000 0 | 100,000 | Form 4 |
| RUSCHE JAMES R SENIOR VICE PRESIDENT | 2017-02-14 19:45:23 | 95,816 0 | 95,816 | Form 5 |
| DAWES KAREN A Director | 2024-08-19 19:29:25 | 91,123 0 | 91,123 | Form 4/A |
| COOPER GLENN L MD Director | 2019-06-19 19:04:13 | 59,709 0 | 59,709 | Form 4/A |
| Whitehouse Laura Vice President | 2007-05-29 15:57:21 | 50,000 0 | 50,000 | Form 4 |
| Benjamin Howard VP Business Development | 2017-12-18 17:59:33 | 45,042 0 | 45,042 | Form 4 |
| Goldberg Alfred Lewis Director | 2015-05-26 18:28:30 | 42,323 0 | 42,323 | Form 4 |
| Snodgres Jon Chief Financial Officer | 2023-05-16 19:00:48 | 37,381 0 | 37,381 | Form 4 |
| Loeillot Olivier Chief Executive Officer | 2024-11-21 13:32:09 | 32,556 0 | 32,556 | Form 4 |
| MUIR GLENN P Director | 2024-11-20 14:29:56 | 32,283 0 | 32,283 | Form 4 |
| Gebski Christine See Remarks | 2024-05-15 20:18:44 | 27,419 0 | 27,419 | Form 4 |
| DAY BARBARA BURNIM Former Vice President | 2006-01-27 17:05:56 | 24,500 0 | 24,500 | Form 4 |
| Henry Earl Webb Director | 2013-05-16 14:13:51 | 21,380 0 | 21,380 | Form 4 |
| Bylund James Chief Operating Officer | 2024-04-04 17:04:02 | 20,591 0 | 20,591 | Form 4 |
| HENNESSEY ROBERT J Director | 2007-09-17 13:06:19 | 20,000 0 | 20,000 | Form 4 |
| LANDY HAL Vice President | 2007-06-20 16:39:54 | 20,000 0 | 20,000 | Form 4 |
| Kelly William J Chief Accounting Officer | 2014-03-03 13:00:50 | 15,907 0 | 15,907 | Form 4 |
| KURIYEL RALF Senior VP, R&D | 2024-08-05 21:56:01 | 12,288 0 | 12,288 | Form 4 |
| GRIFFITH MICHAEL A Director | 2014-11-12 15:08:26 | 9,932 0 | 9,932 | Form 4 |
| Garland Jason K CFO | 2024-11-21 14:10:09 | 7,676 0 | 7,676 | Form 4 |
| EGLINTON MANNER CARRIE Director | 2024-05-20 18:53:14 | 4,869 0 | 4,869 | Form 4 |
| BARTHELEMY NICOLAS Director | 2024-06-14 17:42:58 | 4,668 0 | 4,668 | Form 4 |
| Madaus Martin D Director | 2024-06-14 18:07:59 | 4,613 11 | 4,624 | Form 4 |
| Mhatre Rohin Director | 2024-05-20 19:32:45 | 4,422 0 | 4,422 | Form 4 |
| Konstantinov Konstantin Director | 2024-05-20 19:27:43 | 3,297 0 | 3,297 | Form 4 |
| Pax Margaret Director | 2024-05-20 19:30:31 | 2,169 0 | 2,169 | Form 4 |
| RYAN THOMAS F JR Director | 2022-03-02 21:14:08 | 1,457 0 | 1,457 | Form 4 |
| Cox John Director | 2020-03-26 19:31:58 | 923 0 | 923 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC LAMPERT MARK N BVF INC Indirect Beneficial Owner 10% Owner | 2012-02-10 16:59:45 | 0 0 | 0 | Form 13G |
| MILLER G WILLIAM Director | 2004-09-23 16:07:39 | 0 0 | 0 | Form 4 |